Publizoom

123 Acurae Pharma GmbH

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won
1
Shared contracts
1 (multi-supplier framework agreements)
Period
6 August 2026 – 6 August 2026

Its main clients

Where and what

Supplies · 1

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned endContractCurrent holderAmount
1 October 2027
re-tender around April 2027
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ticagrelor, ATC B01AC24 für die Zeit 01.06.2025 - 31.05.2027 (zzgl. Verlängerungsoption 1x12 Monate)
DAK-Gesundheit
089PHARM GmbH
Abdi Farma GmbH
123 Acurae Pharma GmbH
1 A Pharma GmbH
AstraZeneca GmbH
betapharm Arzneimittel GmbH
BG ALIUD / STADAPHARM GbR
Heumann Pharma GmbH & Co. Generica KG
Holsten Pharma GmbH
Micro Labs GmbH
ratiopharm GmbH
TAD Pharma GmbH
Viatris Healthcare GmbH
Vivanta Generics s.r.o.
Zentiva Pharma GmbH
21 bids received
€1

Contracts won

DateContractBuyerAmount
06/08/2026 Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ticagrelor, ATC B01AC24 für die Zeit 01.06.2025 - 31.05.2027 (zzgl. Verlängerungsoption 1x12 Monate) DAK-Gesundheit €1
shared by 15

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.